BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20096619)

  • 1. Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.
    Marques-Pinheiro A; Levasseur R; Cormier C; Bonneau J; Boileau C; Varret M; Abifadel M; Allanore Y
    Joint Bone Spine; 2010 Mar; 77(2):151-3. PubMed ID: 20096619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.
    Barros ER; Dias da Silva MR; Kunii IS; Lazaretti-Castro M
    J Pediatr Endocrinol Metab; 2008 Aug; 21(8):811-8. PubMed ID: 18825883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A family with osteoporosis pseudoglioma syndrome due to compound heterozygosity of two novel mutations in the LRP5 gene.
    Cheung WM; Jin LY; Smith DK; Cheung PT; Kwan EY; Low L; Kung AW
    Bone; 2006 Sep; 39(3):470-6. PubMed ID: 16679074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.
    Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A
    Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
    Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular findings in osteoporosis-pseudoglioma syndrome.
    Ai M; Heeger S; Bartels CF; Schelling DK;
    Am J Hum Genet; 2005 Nov; 77(5):741-53. PubMed ID: 16252235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).
    Laine CM; Chung BD; Susic M; Prescott T; Semler O; Fiskerstrand T; D'Eufemia P; Castori M; Pekkinen M; Sochett E; Cole WG; Netzer C; Mäkitie O
    Eur J Hum Genet; 2011 Aug; 19(8):875-81. PubMed ID: 21407258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
    Levasseur R; Lacombe D; de Vernejoul MC
    Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates.
    Streeten EA; McBride D; Puffenberger E; Hoffman ME; Pollin TI; Donnelly P; Sack P; Morton H
    Bone; 2008 Sep; 43(3):584-90. PubMed ID: 18602879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5.
    Biha N; Ghaber SM; Hacen MM; Collet C
    Case Rep Genet; 2016; 2016():9814928. PubMed ID: 26904320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.
    Narumi S; Numakura C; Shiihara T; Seiwa C; Nozaki Y; Yamagata T; Momoi MY; Watanabe Y; Yoshino M; Matsuishi T; Nishi E; Kawame H; Akahane T; Nishimura G; Emi M; Hasegawa T
    Am J Med Genet A; 2010 Jan; 152A(1):133-40. PubMed ID: 20034086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
    van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
    JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.
    Abdel-Hamid MS; Elhossini RM; Otaify GA; Abdel-Ghafar SF; Aglan MS
    Osteoporos Int; 2022 Jul; 33(7):1501-1510. PubMed ID: 35106624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Homozygous Nonsense Mutation in the
    Heidari A; Homaei A; Saffari F
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):318-323. PubMed ID: 34965700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment.
    Tüysüz B; Bursalı A; Alp Z; Suyugül N; Laine CM; Mäkitie O
    Horm Res Paediatr; 2012; 77(2):115-20. PubMed ID: 22456437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.
    Alonso N; Soares DC; V McCloskey E; Summers GD; Ralston SH; Gregson CL
    J Bone Miner Res; 2015 Apr; 30(4):615-20. PubMed ID: 25384351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Celli M; D'Eufemia P; Persiani P; Turchetti A; Febbo A; D'Alfonso Y; Celli L; Zambrano A
    Osteoporos Int; 2017 Nov; 28(11):3277-3280. PubMed ID: 28866852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced bone mineral density and hyaloid vasculature remnants in a consanguineous recessive FEVR family with a mutation in LRP5.
    Downey LM; Bottomley HM; Sheridan E; Ahmed M; Gilmour DF; Inglehearn CF; Reddy A; Agrawal A; Bradbury J; Toomes C
    Br J Ophthalmol; 2006 Sep; 90(9):1163-7. PubMed ID: 16929062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism.
    Cook FJ; Mumm S; Whyte MP; Wenkert D
    J Bone Miner Res; 2014 Apr; 29(4):922-8. PubMed ID: 24014470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential blindness in children of patients with hereditary bone disease.
    Kheir V; Munier FL; Aubry-Rozier B; Schorderet DF
    Osteoporos Int; 2016 Feb; 27(2):841-4. PubMed ID: 26243358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.